Results of combined modality treatment for laryngeal and laryngopharyngeal cancers
Автор: Choinzonov E.L., Chizhevskaya S.Yu., Musabaeva L.I., Frolova I.G., Avdeev S.V., Sinilkin I.G., Zelchan R.V., Surkova P.V., Kushner А.V.
Журнал: Сибирский онкологический журнал @siboncoj
Рубрика: Клинические исследования
Статья в выпуске: 1 (49), 2012 года.
Бесплатный доступ
This study evaluated the efficacy of combined modality treatment for 178 patients with histologically confirmed stage II-IV laryngeal and laryngopharyngeal carcinomas during the 2006-2011 period. The use of combined modality treatment including the current anti-tumor agents and radiation therapy regimens allows one to achieve complete tumor regression and avoid surgery in 34,4 ± 4,8 % of cases and to perform organ-preserving and function-sparing surgeries in 31,7 ± 5,8 % of cases, thus improving life quality pf patients
Combined modality treatment, neoadjuvant chemotherapy, multifraction radiation therapy, laryngeal and laryngopharyngeal carcinomas
Короткий адрес: https://sciup.org/14056187
IDR: 14056187
